NCT05617066

Brief Summary

150 patients of legal age will participate in this project, diagnosed with systemic sclerosis. Patients will be randomly assigned, as will be detailed later, to one of the following three groups: Therapy Group (GT): This group will be made up of 50 patients who will receive cognitive behavioral therapy of coping with stress (online modality) in groups of 10-12 people during twelve sessions Consecutive weekly courses of 1.5 to 2 hours duration taught by psychology professionals. of this mode 4 subgroups will be made. Psychological Support Group (AP): This group will be made up of 50 patients who will receive psychoeducation about stress and its consequences and the specific stress suffered by people with a autoimmune disease such as scleroderma. It will have a duration of twelve weekly sessions. Consecutive sessions of 1.5 to 2 hours in length taught by professional psychologists. In this way they will 4 subgroups. Usual Care Group (CG): This group will be made up of 50 patients who will follow their usual care. Later, once the study is over, they will be offered to participate in coping with stress to the person who is interested.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

November 26, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

February 1, 2024

Status Verified

January 1, 2024

Enrollment Period

4 months

First QC Date

November 9, 2022

Last Update Submit

January 31, 2024

Conditions

Keywords

scleroderma, stress, cognitive behavioral therapy

Outcome Measures

Primary Outcomes (1)

  • Cortisol y psychological stress levels

    Decreased cortisol and psychological stress after therapy

    3 months

Secondary Outcomes (1)

  • Quality of life and psychological status

    3 months

Study Arms (2)

therapy vs psychological support and usual care

ACTIVE COMPARATOR

Comparison between therapy groups vs psychological support and usual care. Only one group receive therapy.

Behavioral: Cognitive behavioral therapy

therapy and psychological support versus control group

NO INTERVENTION

Comparison between therapy groups vs psychological support and usual care. Only one group receive therapy.

Interventions

With the cognitive behavioral therapy will work on different aspects for coping and tools psychological stress.

therapy vs psychological support and usual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis made by a specialist doctor, good command of the Spanish language (oral and written comprehension) and have an internet connection.

You may not qualify if:

  • No psychiatric illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Granada

Granada, 18070, Spain

Location

MeSH Terms

Conditions

Scleroderma, Diffuse

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Scleroderma, SystemicConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator. PhD in Psychology. Clinic Psychologist

Study Record Dates

First Submitted

November 9, 2022

First Posted

November 15, 2022

Study Start

November 26, 2022

Primary Completion

March 31, 2023

Study Completion

September 1, 2023

Last Updated

February 1, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations